| Date Filed | Type | Description |
| 06/12/2023 |
4
| Cooper Ronald Harold Wilfred (Director) has filed a Form 4 on Generation Bio Co.|
Txns:
| Granted 25,000 options to buy
@ $4.83, valued at
$120.8k
|
|
| 03/02/2023 |
4
| Cooper Ronald Harold Wilfred (President and CEO) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Unknown transaction of 33,094 shares
@ $0
Disposed/sold 132,150 options to buy
@ $26.75, valued at
$3.5M
Disposed/sold 43,027 options to buy
@ $19.19, valued at
$825.7k
Disposed/sold 93,000 options to buy
@ $34.88, valued at
$3.2M
Disposed/sold 124,000 options to buy
@ $24.67, valued at
$3.1M
Disposed/sold 124,000 options to buy
@ $24.04, valued at
$3M
Disposed/sold 123,750 options to buy
@ $30.68, valued at
$3.8M
Disposed/sold 60,000 options to buy
@ $24.48, valued at
$1.5M
Disposed/sold 19,422 options to buy
@ $1, valued at
$19.4k
Disposed/sold 155,381 options to buy
@ $1, valued at
$155.4k
Disposed/sold 219,350 restricted stock units
@ $0 |
|
| 01/27/2023 |
4/A
| Cooper Ronald Harold Wilfred (President and CEO) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Granted 195,000 shares
@ $0 |
|
| 01/25/2023 |
4
| Cooper Ronald Harold Wilfred (President and CEO) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Granted 195,000 shares
@ $0 |
|
| 01/23/2023 |
4
| Cooper Ronald Harold Wilfred (President and CEO) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Sold 1,057 shares
@ $43.8, valued at
$46.3k
|
|
| 01/09/2023 |
4/A
| Cooper Ronald Harold Wilfred (President and CEO) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Sold 919 shares
@ $19.5764, valued at
$18k
|
|
| 01/09/2023 |
4
| Cooper Ronald Harold Wilfred (Director) has filed a Form 4 on Generation Bio Co.|
Txns:
| Granted 9,500 shares
@ $5.12, valued at
$48.6k
|
|
| 10/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/25/2022 |
4
| Cooper Ronald Harold Wilfred (President and CEO) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Sold 907 shares
@ $33.11, valued at
$30k
|
|
| 01/25/2022 |
4
| Cooper Ronald Harold Wilfred (President and CEO) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Sold 3,684 shares
@ $24.8822, valued at
$91.7k
|
|
| 01/20/2022 |
4
| Cooper Ronald Harold Wilfred (President and CEO) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Granted 132,150 options to buy
@ $26.75, valued at
$3.5M
|
|
| 09/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Cooper Ronald Harold Wilfred (Director) has filed a Form 4 on Generation Bio Co.|
Txns:
| Granted 30,000 options to buy
@ $40.2, valued at
$1.2M
|
|
| 03/03/2021 |
3
| Cooper Ronald Harold Wilfred (Director) has filed a Form 3 on Generation Bio Co. |
| 01/25/2021 |
4
| Cooper Ronald Harold Wilfred (President and CEO) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Granted 48,700 shares
@ $0
Granted 93,000 options to buy
@ $34.88, valued at
$3.2M
|
|
| 06/19/2020 |
4
| Cooper Ronald Harold Wilfred (Director) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.|
Txns:
| Granted 15,000 options to buy
@ $2.22, valued at
$33.3k
|
|
| 01/23/2020 |
4
| Cooper Ronald Harold Wilfred (President and CEO) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Granted 124,000 options to buy
@ $24.67, valued at
$3.1M
|
|
| 07/19/2019 |
4
| Cooper Ronald Harold Wilfred (Director) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.|
Txns:
| Granted 5,625 options to buy
@ $3.66, valued at
$20.6k
|
|
| 01/24/2019 |
4
| Cooper Ronald Harold Wilfred (President and CEO) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Granted 124,000 options to buy
@ $24.04, valued at
$3M
|
|
| 11/15/2018 |
4
| Cooper Ronald Harold Wilfred (President and CEO) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Bought 1,026 shares
@ $25.0177, valued at
$25.7k
|
|
| 08/16/2018 |
4
| Cooper Ronald Harold Wilfred (President and CEO) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Bought 588 shares
@ $31.63, valued at
$18.6k
Bought 200 shares
@ $32.5, valued at
$6.5k
|
|
| 06/25/2018 |
4
| Cooper Ronald Harold Wilfred (Director) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.|
Txns:
| Granted 45,000 options to buy
@ $0.99, valued at
$44.6k
|
|
| 06/11/2018 |
4
| Cooper Ronald Harold Wilfred (President and CEO) has filed a Form 4 on ALBIREO PHARMA, INC.|
Txns:
| Granted 123,750 options to buy
@ $30.68, valued at
$3.8M
|
|
| 08/23/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/24/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/07/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/07/2016 |
3
| Cooper Ronald Harold Wilfred (President and CEO) has filed a Form 3 on ALBIREO PHARMA, INC. |
| 06/14/2016 |
3
| Cooper Ronald Harold Wilfred (Director) has filed a Form 3 on GENOCEA BIOSCIENCES, INC. |